Today, the intersection of life sciences and engineering is seeing more research breakthroughs than any field since silicon in the 70’s. Our IP Centric Healthcare Fund aims to help commercialize breakthroughs with the potential for broad IP, so that multiple commercial applications per innovation accelerates the potential to fundamentally change our experience with healthcare. While we’re open to any game changing innovations – we believe these will often be outside of what we can dream – we are particularly interested in:

Consumer-Driven DiAgnostics

Tools to help consumers understand and manage their health outside the healthcare system.

Improved Status-Quo

Familiar clinical devices made significantly less invasive, cheaper, faster or easier to use. 




Fund Founded


Fund Size

Targeting $45M

Investment Size

$250k - $2.5M